One Global Service Provider Ltd

ONE GLOBAL SERVICE PROVIDER LIMITED, formerly known as Overseas Synthetics Limited, will hold a board meeting on Wednesday, November 4, 2026, to consider and approve the un-audited standalone financial results for the quarter and half year ended September 30, 2026, according to a regulatory filing with the BSE Limited. The company’s trading window for securities will be closed immediately until 48 hours after the board meeting’s conclusion for designated persons and their immediate relatives, in compliance with SEBI regulations.

One Global Service Provider Limited announced the allotment of 7,06,068 fully paid-up equity shares of face value Rs 10 each on a preferential basis for consideration other than cash, following approvals from the board of directors on September 3, 2026, and shareholders at the Annual General Meeting on September 29, 2026. The allotment was approved by the board through circulation on Wednesday, October 28, 2026, with Mr. Suresh receiving 6,57,748 shares and Ms. Nithya receiving 48,320 shares.

One Global Service Provider Limited, a Mumbai-based service provider, submitted a certificate to the BSE Ltd on October 8, 2026, confirming compliance with Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended September 30, 2026, as processed by MCS Share Transfer Agent Limited, the company's Registrar and Share Transfer Agent.

ONE GLOBAL SERVICE PROVIDER LIMITED, formerly known as Overseas Synthetics Limited, will close its trading window for designated persons and their immediate relatives from October 1, 2026, until 48 hours after a board meeting to consider the company’s unaudited financial results for the quarter and half-year ended September 30, 2026, according to a filing with the BSE Limited.

One Global Service Provider Limited (OGSPL) has amended share purchase agreements to adjust the issue price of shares being issued to sellers in its acquisition of equity in Matrix Labs Private Limited (MLPL). The transactions, originally dated September 3, 2026, and amended on September 18, 2026, involve the acquisition of 2,550 shares, representing 51% of MLPL, for a total consideration of Rs 3,56,35,320. The per-share issue price is Rs 558.99, with a premium of Rs 548.99. While the overall deal value remains unchanged, the adjustments are intended to strengthen OGSPL’s presence in the diagnostic, pathology, and allied healthcare sectors and are not expected to have an adverse impact on the company’s business. The acquisition of a second Matrix Labs Private Limited entity also carries a total consideration of Rs 3,56,35,320 with the same per-share price and premium.

One Global Service Provider Limited, formerly known as Overseas Synthetics Limited, will hold its 34th Annual General Meeting on September 29, 2026, at 2:00 P.M. (IST) via video conferencing, and the company’s Register of Members and Share Transfer Books will be closed from September 22, 2026, to September 29, 2026, for the purpose of the meeting and payment of dividend for the financial year ended March 31, 2026.

One Global Service Provider Limited, formerly known as Overseas Synthetics Limited, will hold its 34th Annual General Meeting on September 29, 2026, at 2:00 P.M. (IST) via video conferencing, and the company’s Register of Members and Share Transfer Books will be closed from September 22, 2026, to September 29, 2026, for the purpose of the meeting and payment of dividend for the financial year ended March 31, 2026. The company has set September 22, 2026, as the record date for remote e-voting.

One Global Service Provider Limited is increasing its authorized share capital from Rs. 25,05,00,000 to Rs. 50,00,00,000 through a preferential allotment of equity shares and the acquisition of Matrix Labs Diagnocare Private Limited and Matrix Labs Private Limited. The company will allot 7,15,040 shares at a price of Rs. 553 per share, with Mr. Suresh receiving 6,66,200 shares, representing a 3.29% stake, and Mr. Nithya S receiving 48,840 shares, or 0.24% of the company. The total consideration for the acquisitions is Rs. 3,56,35,320 for each target company. The transaction, which involves related parties, requires scrutiny, and the ultimate beneficiaries of the selling shareholders are currently listed as "Not Applicable," raising questions about potential conflicts of interest.

One Global Service Provider Limited is undertaking a preferential allotment of 7,15,040 equity shares at a price of Rs. 553 per share to investors Mr. Suresh and Mr. Nithya S, as part of a larger acquisition of stakes in Matrix Labs Diagnocare Private Limited (MLDPL) and Matrix Labs Private Limited (MLPL). The allotment, approved to increase the company’s authorized share capital from Rs. 25,05,00,000 to Rs. 50,00,00,000, will grant Mr. Suresh a 3.29% stake and Mr. Nithya S a 0.24% stake in One Global. The company plans to acquire 51% equity in both MLDPL, where Mr. Suresh holds 95% and Mr. Nithya S holds 5%, and MLPL, where Mr. Suresh holds 70%. Significant discrepancies exist regarding the number of shares involved in the transaction, and further clarification is needed regarding the ultimate beneficiaries of the investors and a complete accounting of shareholdings before and after the allotment.

One Global Service Provider Limited is acquiring a 51% stake in Matrix Labs Diagnocare Private Limited (MLDPL) and Matrix Labs Private Limited (MLPL) through a preferential allotment of 7,15,040 equity shares. The consideration for the acquisition is non-cash, consisting of equity shares issued to Mr. Suresh and Mr. Nithya S, who are selling portions of their ownership in the companies. Mr. Suresh will receive 6,66,200 shares, representing a 3.29% stake in One Global Service Provider Limited, while Mr. Nithya S will receive 48,840 shares, or 0.24% of the company. The share issuance price is Rs. 553 per share, a premium over the face value. Simultaneously, the company is increasing its authorized share capital from Rs. 25,05,00,000 to Rs. 50,00,00,000 through an amendment to its Memorandum of Association. Discrepancies exist regarding the total number of shares issued, and further clarification is needed regarding the acquisition details and beneficiary information.